Predictive factors for survival in neoadjuvant radiochemotherapy for advanced rectal cancer

被引:2
|
作者
Reig Castillejo, A. [1 ]
Membrive, I. [1 ]
Foro, P. [1 ]
Quera, J. [1 ]
Sanz, X. [1 ]
Rodriguez, N. [1 ]
Fernandez-Velilla, E. [1 ]
Pera, O. [1 ]
Ortiz, A. [1 ]
Algara, M. [1 ]
机构
[1] Hosp Esperanza, Dept Radiat & Oncol, Parc Salut Mar,C St Josep de la Muntanya 12, Barcelona 08024, Spain
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2017年 / 19卷 / 07期
关键词
Rectal carcinoma; Predictive factors; Radiochemotherapy; Overall survival; PREOPERATIVE CHEMORADIOTHERAPY; PERINEURAL INVASION; TUMOR-REGRESSION; COLORECTAL-CANCER; RESECTION; RADIOTHERAPY; METASTASES; CARCINOMA; MARGIN;
D O I
10.1007/s12094-017-1612-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Neoadjuvant radiochemotherapy followed by radical surgery is the standard approach in advanced rectal carcinoma. Tumor response is determined in histological specimen. Objective To assess predictive factors for survival in 115 patients. Patients and Method 115 patients treated with neoadjuvant radiochemotherapy followed by radical surgery with total mesorectal excision, in our hospital from January 2007 to December 2014. All patients received pelvic radiotherapy with concomitant chemotherapy, followed by radical surgery and in some adjuvant chemotherapy. Results In univariate analysis, distance to anal verge, radial margin, perineural invasion, and good grade regression are predictive factors for both, specific and disease free survival; and in multivariant, only radial margin and perineural invasion were predictive factors for survival. We found distance to anal verge (< 5 cm) as the only clinical factor to predict a positive margin in the histologic specimen. Conclusions Perineural invasion and positive radial margin are predictive factors for both specific and disease free survival.
引用
收藏
页码:853 / 857
页数:5
相关论文
共 50 条
  • [31] Neoadjuvant radiochemotherapy with 5-FU plus Oxaliplatin for locally advanced rectal cancer
    Roedel, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (05) : 446 - 447
  • [32] Neoadjuvant radiochemotherapy for patients with locally advanced rectal cancer leads to impairment of the anal sphincter
    Joerg Theisen
    Werner K.- H. Kauer
    Hjalmar Nekarda
    Ludwig Schmid
    Hubert J. Stein
    Joerg-Ruediger Siewert
    Journal of Gastrointestinal Surgery, 2006, 10 : 309 - 314
  • [33] Neoadjuvant radiochemotherapy in advanced rectal cancer: results of a retrospective study, sphincter preservation rate
    Ayad, M.
    Boualga, K.
    Haoui, M.
    Aksil, N.
    ANNALS OF ONCOLOGY, 2016, 27 : 97 - 97
  • [34] Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer
    Rizzo, G.
    Zaccone, G.
    Magnocavallo, M.
    Mattana, C.
    Pafundi, D. P.
    Gambacorta, M. A.
    Valentini, V.
    Coco, C.
    EJSO, 2017, 43 (08): : 1488 - 1493
  • [35] Neoadjuvant radiochemotherapy with irinotecan (CPT-11) and capecitabine in locally advanced rectal cancer
    Kraus-Tiefenbacher, U
    Hofheinz, R
    von Gerstenberg-Heffdorf, B
    Willeke, F
    Hochhaus, A
    Wenz, F
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 31 - 31
  • [37] Analyses of predictive factors for pathological complete remission in neoadjuvant therapy for locally advanced rectal cancer
    Yang, Jun
    Ling, Xin
    Tang, Wen
    Hu, Duanmin
    Zhou, Haiyun
    Yin, Guojian
    JOURNAL OF BUON, 2019, 24 (01): : 77 - 83
  • [39] Rapid remission after neoadjuvant radiochemotherapy of an advanced cancer of the rectal-sigmoidal passage
    Weise, C.
    Ruff, S.
    Roeser, A.
    Schilcher, R. B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 114 - 115
  • [40] Adjuvant therapy of rectal cancer following neoadjuvant radiochemotherapy
    Kuetting, Fabian
    Alakus, Hakan
    Bruns, Christiane
    ONKOLOGE, 2020, 26 (02): : 185 - 186